View in EDS PDF Full Text

Lipid nanoparticle-formulated DNA acts as a potent immune modulator for cancer immunotherapy through interferon signaling pathways.

Saved in:
Bibliographic Details
Title: Lipid nanoparticle-formulated DNA acts as a potent immune modulator for cancer immunotherapy through interferon signaling pathways.
Authors: Chiang CY; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Hsieh MS; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Chen MY; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Tsai YW; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Lin CL; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Hsu CW; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Yu GY; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Huang MH; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan., Liu SJ; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan., Chen HW; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Source: Theranostics [Theranostics] 2026 Jan 01; Vol. 16 (5), pp. 2342-2356. Date of Electronic Publication: 2026 Jan 01 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41424839
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lipid nanoparticle-formulated DNA acts as a potent immune modulator for cancer immunotherapy through interferon signaling pathways.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chiang+CY%22">Chiang CY</searchLink>; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hsieh+MS%22">Hsieh MS</searchLink>; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+MY%22">Chen MY</searchLink>; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.<br /><searchLink fieldCode="AU" term="%22Tsai+YW%22">Tsai YW</searchLink>; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+CL%22">Lin CL</searchLink>; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hsu+CW%22">Hsu CW</searchLink>; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yu+GY%22">Yu GY</searchLink>; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.<br /><searchLink fieldCode="AU" term="%22Huang+MH%22">Huang MH</searchLink>; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Liu+SJ%22">Liu SJ</searchLink>; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+HW%22">Chen HW</searchLink>; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101552395%22">Theranostics</searchLink> [Theranostics] 2026 Jan 01; Vol. 16 (5), pp. 2342-2356. <i>Date of Electronic Publication: </i>2026 Jan 01 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ivyspring+International+Publisher%22">Ivyspring International Publisher </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101552395 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1838-7640 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218387640%22">18387640 </searchLink><i>NLM ISO Abbreviation: </i>Theranostics <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41424839
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.7150/thno.121364
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2342
    Titles:
      – TitleFull: Lipid nanoparticle-formulated DNA acts as a potent immune modulator for cancer immunotherapy through interferon signaling pathways.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chiang CY
      – PersonEntity:
          Name:
            NameFull: Hsieh MS
      – PersonEntity:
          Name:
            NameFull: Chen MY
      – PersonEntity:
          Name:
            NameFull: Tsai YW
      – PersonEntity:
          Name:
            NameFull: Lin CL
      – PersonEntity:
          Name:
            NameFull: Hsu CW
      – PersonEntity:
          Name:
            NameFull: Yu GY
      – PersonEntity:
          Name:
            NameFull: Huang MH
      – PersonEntity:
          Name:
            NameFull: Liu SJ
      – PersonEntity:
          Name:
            NameFull: Chen HW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1838-7640
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Theranostics
              Type: main
ResultId 1